OTCMKTS:PECN

Photoelectron Competitors

$0.0037
0.00 (0.00 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range
$0.00
MA: $0.01
$0.03
52-Week Range
$0.00
Now: $0.00
$0.05
Volume1,000 shs
Average Volume25,470 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta3.6

Competitors

Photoelectron (OTCMKTS:PECN) Vs. MDT, SONVY, VAR, MASI, GNGBY, and LIVN

Should you be buying PECN stock or one of its competitors? Companies in the industry of "electromedical equipment" are considered alternatives and competitors to Photoelectron, including Medtronic (MDT), Sonova (SONVY), Varian Medical Systems (VAR), Masimo (MASI), Getinge (GNGBY), and LivaNova (LIVN).

Medtronic (NYSE:MDT) and Photoelectron (OTCMKTS:PECN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership.

Risk & Volatility

Medtronic has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Photoelectron has a beta of 3.6, indicating that its stock price is 260% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Medtronic and Photoelectron, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medtronic031912.91
Photoelectron0000N/A

Medtronic currently has a consensus target price of $125.3333, indicating a potential downside of 2.30%. Given Medtronic's higher possible upside, equities analysts clearly believe Medtronic is more favorable than Photoelectron.

Profitability

This table compares Medtronic and Photoelectron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medtronic12.69%9.71%5.30%
PhotoelectronN/AN/AN/A

Institutional & Insider Ownership

79.2% of Medtronic shares are owned by institutional investors. 0.5% of Medtronic shares are owned by insiders. Comparatively, 50.5% of Photoelectron shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Medtronic and Photoelectron's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$28.91 billion5.98$4.79 billion$4.5927.95
PhotoelectronN/AN/AN/AN/AN/A

Medtronic has higher revenue and earnings than Photoelectron.

Summary

Medtronic beats Photoelectron on 8 of the 10 factors compared between the two stocks.

Sonova (OTCMKTS:SONVY) and Photoelectron (OTCMKTS:PECN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Sonova and Photoelectron, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Sonova06302.33
Photoelectron0000N/A

Profitability

This table compares Sonova and Photoelectron's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
SonovaN/AN/AN/A
PhotoelectronN/AN/AN/A

Risk & Volatility

Sonova has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Photoelectron has a beta of 3.6, indicating that its stock price is 260% more volatile than the S&P 500.

Earnings & Valuation

This table compares Sonova and Photoelectron's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sonova$2.96 billion6.35$489.96 million$1.4939.13
PhotoelectronN/AN/AN/AN/AN/A

Sonova has higher revenue and earnings than Photoelectron.

Institutional & Insider Ownership

1.1% of Sonova shares are owned by institutional investors. 50.5% of Photoelectron shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Sonova beats Photoelectron on 3 of the 5 factors compared between the two stocks.

Photoelectron (OTCMKTS:PECN) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation.

Analyst Recommendations

This is a summary of recent ratings and target prices for Photoelectron and Varian Medical Systems, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Photoelectron0000N/A
Varian Medical Systems15001.83

Varian Medical Systems has a consensus price target of $170.9167, indicating a potential downside of 3.48%. Given Varian Medical Systems' higher possible upside, analysts clearly believe Varian Medical Systems is more favorable than Photoelectron.

Profitability

This table compares Photoelectron and Varian Medical Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PhotoelectronN/AN/AN/A
Varian Medical Systems8.50%18.45%8.08%

Volatility and Risk

Photoelectron has a beta of 3.6, suggesting that its share price is 260% more volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500.

Earnings and Valuation

This table compares Photoelectron and Varian Medical Systems' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PhotoelectronN/AN/AN/AN/AN/A
Varian Medical Systems$3.17 billion5.13$269.20 million$3.9145.29

Varian Medical Systems has higher revenue and earnings than Photoelectron.

Insider and Institutional Ownership

87.0% of Varian Medical Systems shares are owned by institutional investors. 50.5% of Photoelectron shares are owned by company insiders. Comparatively, 0.8% of Varian Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Varian Medical Systems beats Photoelectron on 6 of the 8 factors compared between the two stocks.

Photoelectron (OTCMKTS:PECN) and Masimo (NASDAQ:MASI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation.

Analyst Recommendations

This is a summary of recent ratings and target prices for Photoelectron and Masimo, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Photoelectron0000N/A
Masimo02502.71

Masimo has a consensus price target of $272.20, indicating a potential upside of 11.78%. Given Masimo's higher possible upside, analysts clearly believe Masimo is more favorable than Photoelectron.

Profitability

This table compares Photoelectron and Masimo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PhotoelectronN/AN/AN/A
Masimo20.30%15.75%13.12%

Volatility and Risk

Photoelectron has a beta of 3.6, suggesting that its share price is 260% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500.

Earnings and Valuation

This table compares Photoelectron and Masimo's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PhotoelectronN/AN/AN/AN/AN/A
Masimo$937.84 million14.28$196.22 million$3.2275.62

Masimo has higher revenue and earnings than Photoelectron.

Insider and Institutional Ownership

81.6% of Masimo shares are owned by institutional investors. 50.5% of Photoelectron shares are owned by company insiders. Comparatively, 11.5% of Masimo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Masimo beats Photoelectron on 7 of the 9 factors compared between the two stocks.

Photoelectron (OTCMKTS:PECN) and Getinge (OTCMKTS:GNGBY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation.

Volatility and Risk

Photoelectron has a beta of 3.6, suggesting that its share price is 260% more volatile than the S&P 500. Comparatively, Getinge has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500.

Insider and Institutional Ownership

0.0% of Getinge shares are owned by institutional investors. 50.5% of Photoelectron shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Photoelectron and Getinge's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PhotoelectronN/AN/AN/A
Getinge10.51%17.30%7.90%

Analyst Recommendations

This is a summary of recent ratings and target prices for Photoelectron and Getinge, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Photoelectron0000N/A
Getinge11502.57

Earnings and Valuation

This table compares Photoelectron and Getinge's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PhotoelectronN/AN/AN/AN/AN/A
Getinge$2.81 billion2.88$129.29 millionN/AN/A

Getinge has higher revenue and earnings than Photoelectron.

Summary

Getinge beats Photoelectron on 6 of the 8 factors compared between the two stocks.

Photoelectron (OTCMKTS:PECN) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership and risk.

Volatility and Risk

Photoelectron has a beta of 3.6, suggesting that its share price is 260% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500.

Insider & Institutional Ownership

89.1% of LivaNova shares are owned by institutional investors. 50.5% of Photoelectron shares are owned by company insiders. Comparatively, 0.5% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Photoelectron and LivaNova's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PhotoelectronN/AN/AN/A
LivaNova-21.88%5.55%3.07%

Analyst Ratings

This is a summary of recent ratings and recommmendations for Photoelectron and LivaNova, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Photoelectron0000N/A
LivaNova04202.33

LivaNova has a consensus price target of $69.3333, indicating a potential downside of 14.86%. Given LivaNova's higher possible upside, analysts plainly believe LivaNova is more favorable than Photoelectron.

Earnings & Valuation

This table compares Photoelectron and LivaNova's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PhotoelectronN/AN/AN/AN/AN/A
LivaNova$1.08 billion3.65$-155,180,000.00$3.0826.44

Photoelectron has higher earnings, but lower revenue than LivaNova.

Summary

LivaNova beats Photoelectron on 6 of the 9 factors compared between the two stocks.


Photoelectron Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Medtronic logo
MDT
Medtronic
2.7$128.28flat$172.93 billion$28.91 billion48.96
Sonova logo
SONVY
Sonova
0.9$58.30flat$18.87 billion$2.96 billion39.13Analyst Downgrade
Varian Medical Systems logo
VAR
Varian Medical Systems
1.3$177.07flat$16.26 billion$3.17 billion60.43
Masimo logo
MASI
Masimo
1.6$243.51flat$13.39 billion$937.84 million63.25Upcoming Earnings
News Coverage
Getinge logo
GNGBY
Getinge
0.6$31.80flat$8.08 billion$2.81 billion26.28News Coverage
LivaNova logo
LIVN
LivaNova
1.5$81.43flat$3.96 billion$1.08 billion-18.94Analyst Report
News Coverage
CONMED logo
CNMD
CONMED
1.6$128.08flat$3.72 billion$955.10 million-3,202.00Analyst Revision
News Coverage
InMode logo
INMD
InMode
1.5$83.99flat$2.69 billion$156.36 million60.42
Outset Medical logo
OM
Outset Medical
1.1$55.50flat$2.38 billionN/A0.00Analyst Report
BioLife Solutions logo
BLFS
BioLife Solutions
2.1$31.51flat$1.05 billion$27.37 million-43.16Insider Selling
Increase in Short Interest
NTUS
Natus Medical
1.1$26.98flat$913.92 million$495.52 million-49.05
AxoGen logo
AXGN
AxoGen
1.7$18.28flat$745.31 million$106.71 million-29.02News Coverage
SMLR
Semler Scientific
1.2$106.88flat$738.87 million$32.77 million75.26
TransMedics Group logo
TMDX
TransMedics Group
1.6$25.04flat$685.35 million$23.60 million-17.89Increase in Short Interest
ViewRay logo
VRAY
ViewRay
1.5$3.94flat$633.56 million$87.78 million-4.43News Coverage
Stereotaxis logo
STXS
Stereotaxis
0.6$7.68flat$603.75 million$28.90 million-69.82
Zynex logo
ZYXI
Zynex
1.8$14.82flat$540.60 million$45.47 million44.91News Coverage
Cutera logo
CUTR
Cutera
1.5$27.50flat$489.03 million$181.71 million-15.19News Coverage
Edap Tms logo
EDAP
Edap Tms
1.3$8.33flat$242.94 million$50.23 million-138.83Increase in Short Interest
Gap Down
Second Sight Medical Products logo
EYES
Second Sight Medical Products
0.8$7.34flat$204.85 million$3.38 million-3.84Decrease in Short Interest
FONR
FONAR
1.1$17.62flat$115.48 million$85.69 million16.62
IRIDEX logo
IRIX
IRIDEX
0.9$7.07flat$109.73 million$43.45 million-12.85
BioSig Technologies logo
BSGM
BioSig Technologies
0.5$3.43flat$109.04 millionN/A0.00
ENDRA Life Sciences logo
NDRA
ENDRA Life Sciences
0.6$2.20flat$91.52 million$10,000.00-1.20Analyst Downgrade
Soleno Therapeutics logo
SLNO
Soleno Therapeutics
1.9$1.10flat$87.70 millionN/A-1.45Analyst Downgrade
Increase in Short Interest
Electromed logo
ELMD
Electromed
1.8$10.10flat$87.21 million$32.47 million24.05News Coverage
electroCore logo
ECOR
electroCore
1.4$1.74flat$84.35 million$2.39 million-2.20Gap Down
Helius Medical Technologies logo
HSDT
Helius Medical Technologies
1.3$17.10flat$39.52 million$1.50 million-0.98
Fc Global Realty logo
FCRE
Fc Global Realty
0.5$0.10flat$38.87 million$40,000.000.00Gap Up
CHF Solutions logo
CHFS
CHF Solutions
1.7$5.03flat$30.37 million$5.51 million-0.10Increase in Short Interest
News Coverage
ReShape Lifesciences logo
RSLS
ReShape Lifesciences
0.6$3.95flat$27.75 million$15.09 million0.00Gap Up
Viveve Medical logo
VIVE
Viveve Medical
0.9$2.63flat$26.48 million$6.57 million-0.01
PEYE
Precision Optics
0.4$1.70flat$22.55 million$9.92 million-17.00
Vaso logo
VASO
Vaso
0.9$0.09flat$16.46 million$75.75 million4.45News Coverage
Gap Down
Star Equity logo
STRR
Star Equity
0.1$2.76flat$13.59 million$114.18 million-0.88
GTHP
Guided Therapeutics
0.3$0.72flat$10.54 million$40,000.00-3.00
Micron Solutions logo
MICR
Micron Solutions
0.1$3.13flat$10.33 million$17.50 million22.32Increase in Short Interest
NIMU
Non-Invasive Monitoring Systems
0.5$0.03flat$2.49 millionN/A0.00Upcoming Earnings
RSLSD
ReShape Lifesciences
0.4N/AN/A$1.94 million$610,000.000.00High Trading Volume
MAGAA
Magna-Lab
0.7$1.24flat$1.46 millionN/A6.89
Nexeon MedSystems logo
NXNN
Nexeon MedSystems
0.7$0.55flat$1.12 millionN/A0.00
ARDMQ
Aradigm
0.0$0.05flat$764,000.00N/A0.00
SCIE
SpectraScience
0.5$0.00flat$265,000.00N/A0.00
Echo Therapeutics logo
ECTE
Echo Therapeutics
0.5$0.02flat$234,000.00N/A0.00
IMRIS logo
IMRSQ
IMRIS
0.5$0.00flat$166,000.00N/A0.00Gap Up
ULGX
Urologix
0.6$0.01flat$111,000.00N/A0.00Gap Down
AKSY
Aksys
0.0$0.05flat$0.00N/A0.00Gap Down
Escalon Medical logo
ESMC
Escalon Medical
0.5$0.40flat$0.00$9.40 million-6.67
HRTT
Heart Tronics
0.0$0.02flat$0.00N/A0.00
IVVI
Ivivi Technologies
0.0$0.00flat$0.00N/A0.00High Trading Volume
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.